The Targeted RNA Sequencing market is booming, projected to hit $10.97 billion by 2025 with a 22% CAGR. Discover key drivers, trends, and regional insights in this comprehensive market analysis covering NGS technologies, applications (cancer diagnostics, personalized medicine), and leading companies like Illumina and Thermo Fisher.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
